$443 Million is the total value of Foresite Capital Management IV, LLC's 15 reported holdings in Q3 2020. The portfolio turnover from Q2 2020 to Q3 2020 was - .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
RLAY | New | Relay Therapeutics, Inc. | $91,116,000 | – | 2,139,380 | +100.0% | 20.55% | – |
NRIX | New | Nurix Therapeutics, Inc. | $81,969,000 | – | 2,348,014 | +100.0% | 18.48% | – |
ALXO | New | ALX Oncology Holdings Inc. | $36,740,000 | – | 973,514 | +100.0% | 8.28% | – |
ABUS | New | Arbutus Biopharma Corp | $10,431,000 | – | 3,332,616 | +100.0% | 2.35% | – |
RACA | New | Therapeutics Acquisition Corp | $5,033,000 | – | 350,000 | +100.0% | 1.14% | – |
PANAU | New | Panacea Acquisition Corpunit | $1,800,000 | – | 150,000 | +100.0% | 0.41% | – |
ACRS | New | Aclaris Therapeutics, Inc. | $372,000 | – | 144,874 | +100.0% | 0.08% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2020-11-13
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
CymaBay Therapeutics, Inc. | 23 | Q3 2023 | 14.8% |
Aclaris Therapeutics, Inc. | 18 | Q3 2023 | 18.9% |
Kura Oncology, Inc. | 16 | Q3 2023 | 11.7% |
Kinnate Biopharma Inc. | 12 | Q3 2023 | 41.8% |
Myokardia, Inc. | 12 | Q3 2020 | 17.8% |
Pharvaris N.V. | 11 | Q3 2023 | 43.4% |
Cytokinetics Incorporated | 11 | Q2 2021 | 31.6% |
Lyell Immunopharma, Inc. | 10 | Q3 2023 | 29.2% |
Insmed Incorporated | 10 | Q1 2020 | 19.2% |
Biohaven Pharmaceutical Holding Company Ltd. | 9 | Q1 2020 | 14.5% |
View Foresite Capital Management IV, LLC's complete holdings history.
Latest filings
Type | Filed |
---|---|
13F-HR | 2024-05-15 |
4 | 2024-04-05 |
13F-HR | 2024-02-13 |
13F-HR | 2023-11-13 |
13F-HR | 2023-08-11 |
13F-HR | 2023-05-12 |
4 | 2023-05-10 |
4 | 2023-02-22 |
13F-HR | 2023-02-13 |
13F-HR | 2022-11-14 |
View Foresite Capital Management IV, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.